MEDIBANK PRIVATE LIMITED (MPL)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

MPL - MEDIBANK PRIVATE LIMITED

FNArena Sector : Insurance
Year End: June
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

Medibank Private is the largest Australian private health insurance provider. Previously an Australian Government business enterprise, established by the Whitlam government in 1975, it was privatised in 2014.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$3.69

17 Apr
2024

0.050

OPEN

$3.67

1.37%

HIGH

$3.71

4,671,516

LOW

$3.66

TARGET
$3.81 3.3% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . NHF . NOL . PSI . QBE . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
MPL: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx N/A 20.1 xxx
DPS (cps) xxx N/A 16.1 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 18.2 xxx
Dividend Yield xxx N/A 4.4% xxx
Div Pay Ratio(%) xxx N/A 80.2% xxx

Dividend yield today if purchased 3 years ago: 5.07%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

4.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/02 - ex-div 7.2c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx18.6
DPS All xxxxxxxxxxxxxxx14.6
Sales/Revenue xxxxxxxxxxxxxxx7,460.1 M
Book Value Per Share xxxxxxxxxxxxxxx75.7
Net Operating Cash Flow xxxxxxxxxxxxxxx258.2 M
Net Profit Margin xxxxxxxxxxxxxxx6.85 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx25.36 %
Return on Invested Capital xxxxxxxxxxxxxxx24.93 %
Return on Assets xxxxxxxxxxxxxxx11.43 %
Return on Equity xxxxxxxxxxxxxxx25.36 %
Return on Total Capital xxxxxxxxxxxxxxx35.16 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-124.1 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx31 M
Long Term Debt xxxxxxxxxxxxxxx24 M
Total Debt xxxxxxxxxxxxxxx55 M
Goodwill - Gross xxxxxxxxxxxxxxx283 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx421 M
Price To Book Value xxxxxxxxxxxxxxx4.65

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx41.9 M
Capex % of Sales xxxxxxxxxxxxxxx0.56 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx869 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx2,878 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.2

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

23/02/2024

3

Neutral

$3.60

-2.44%

Macquarie does not quantify Medibank Private's result other than to suggest FY24 claims inflation expectations have improved but this will be transitory. Expenses and policyholder growth expectations were both downgraded.

Cyber costs will extend into FY25, albeit at a declining rate.

With current valuations appearing fair, Macquarie awaits the next few data points of Medicare claims inflation to judge the pace of the claims catch-up.

Target falls to $3.60 from $3.65, Neutral retained.

FORECAST
Macquarie forecasts a full year FY24 dividend of 15.70 cents and EPS of 19.40 cents.
Macquarie forecasts a full year FY25 dividend of 15.40 cents and EPS of 20.10 cents.

Citi

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

MPL STOCK CHART